Ionis Pharmaceuticals | IONS - 销售成本



金融业
股票价格
USD
资产
USD 2.99B
现金及等价物
USD 350.07M
销售成本
USD 2.74M
流动资产
USD 2.49B
流动负债
USD 315.64M
债务
USD 1.91B
EBIT
USD -102.29M
EBITDA
USD -64.53M
员工
1.07K
EPS每股收益
USD -0.69
股本和储备
USD 439.74M
销售毛利
USD 265M
债务利息支出
USD 18M
利息收入
USD -0.66
贷款资金
USD 1.91B
市值
USD 8.24B
净收入
USD -114.65M
营业费用
USD 370.24M
营业利润
USD -102.29M
普通股股本
USD 165.64M
PE价格收益
396.15
税前利润
USD -114M
销售收入
USD 268M
销售和管理费用
USD 130.08M
股票
USD 50.83M
贸易债权人
USD 47.7M
应收帐款人
USD 58.85M


销售成本 更改 日
Agios Pharmaceuticals USD 1.32M 560K 2026-03
Alnylam Pharmaceuticals USD 298.45M 87.33M 2026-06
Astellas Pharma JPY 158.38B 28.94B 2026-06
BioCryst Pharmaceuticals USD 3.84M 5.68M 2026-06
BioMarin Pharmaceutical USD 276.29M 76.8M 2026-06
Celltrion KRW 92.83B 14.59B 2026-03
Cspc Pharmaceutical CNY 2.11B 173.58M 2025-12
Deva Holding AS TRY 991.13M 182.81M 2023-09
Divis Laboratories Ltd INR 11.19B 1.2B 2026-06
Exelixis USD 20.66M 704K 2026-06
Halozyme Therapeutics USD 108.68M 67K 2026-06
Ionis Pharmaceuticals USD 2.74M 261K 2026-06
Kangmei Pharma CNY 841.45M 271.27M 2026-03
Knight Therapeutics CAD 82.22M 1.03M 2025-12
Laboratorios Farma EUR 186.09M 11.06M 2023-12
Medical Developments International AUD 7.09M 4.91M 2025-12
Moderna USD 93M 862M 2026-06
Nektar Therapeutics USD 4.43M 5.3M 2024-09
Neuren Pharmaceuticals AUD 7.45M 6.56M 2025-06
Neurocrine Biosciences USD 39.4M 25.6M 2026-06
Novartis USD 3.71B 251M 2026-06
Omeros USD 33.16M 18.52M 2024-06
OPKO Health USD 78.44M 25.04M 2026-03
Organigram Holdings CAD 43.39M 13.54M 2026-03
Pfizer USD 4.09B 498M 2026-06
Pharma Mar EUR 4.73M 1.08M 2026-06
PTC Therapeutics USD 39.61M 23.31M 2026-03
Qiagen NV USD 196.45M 13.73M 2026-06
Regeneron Pharmaceuticals USD 576.5M 92.9M 2026-06
Roche Holding CHF 7.85B 630M 2026-06
Sarepta Therapeutics USD 150.1M 40.64M 2026-06
Sartorius EUR 478.7M 5.9M 2026-06
Sino Biopharmaceutical CNY 3.08B 589.65M 2025-06
Tilray USD 164.37M 8.41M 2025-09
Ultragenyx Pharmaceutical USD 30M 1000K 2026-03
Vertex Pharmaceuticals USD 489.2M 96.4M 2026-06
Zealand Pharma A/S 410K 5K 2025-06
Zz Pientze Pharmaceu CNY 1.58B 245.15M 2026-03